A Study on the Epidemiology and Testing of Human Epidermal Growth Factor-Receptor 2 (HER2) in Breast Cancer in Germany
NCT ID: NCT02666261
Last Updated: 2019-03-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
15000 participants
OBSERVATIONAL
2016-03-04
2018-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Praegnant Breast Cancer: Early/Advanced/Metastatic
NCT02338167
HER2-positive Breast Cancer Registry
NCT06603597
COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer
NCT05906407
"Observational, Retrospective and Prospective, Non-interventional, Multicentre on the Use of Genomic Testing in the Management of Early Stage HR+/HER2- Breast Cancer"
NCT06871501
Analysis of Circulating Tumor DNA (ctDNA) in HER2-low Advanced/Metastatic Breast Cancer
NCT06706557
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Breast Cancer Pathology Samples
Data on the epidemiology and HER2 testing of breast cancer will be collected from pathology routine diagnostics.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Samples derived from participants with any stage of histologically confirmed invasive breast cancer with HER2 diagnostics performed within routine (histo-)pathological workup or
* (Histo-)Pathological work-up of the tumor sample as at or after start of this study
* Available information on the year of birth of the participant
* No pre-selection of tumor samples is allowed. Tumor samples have to be documented consecutively in the order of their (histo-)pathological work-up.
Exclusion Criteria
* Samples derived prior to the start of this study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Klinikum Augsburg; Institut für Pathologie
Augsburg, , Germany
Sozialstiftung Bamberg; Institut für Pathologie
Bamberg, , Germany
Klinikum Bayreuth
Bayreuth, , Germany
Institut für Pathologie, Zytologie & Molekularpathologie in Bergisch Gladbach
Bergisch Gladbach, , Germany
Gemeinschaftspraxis für Pathologie Stefan Berger, Jörg Linke und Ellen Fietze
Berlin, , Germany
Vivantes Klinikum Neukölln; Fachbereich Pathologie
Berlin, , Germany
HELIOS Klinikum Emil von Behring Klinik f.Pneumologie Onkologie u.Infektiologie
Berlin, , Germany
Gemeinschaftspraxis; Institut für Pathologie am Evangelischen Waldkrankenhaus
Berlin - Spandau, , Germany
Praxis am St. Agnes-Hospital Bocholt
Bocholt, , Germany
Institut für Pathologie und Zytologie an der Augusta-Kranken-Anstalt
Bochum, , Germany
Universitätsklinikum Bonn; Zentrum für Pathologie Pathologisches Institut
Bonn, , Germany
Klinikum Coburg GmbH - Institut für Pathologie
Coburg, , Germany
Institut f. Pathologie, der Univers. Köln
Cologne, , Germany
Kliniken der Stadt Köln gGmbH Krankenhaus Merheim
Cologne, , Germany
Städtisches Klinikum Dessau; Institut für Pathologie
Dessau, , Germany
Gemeinschaftspraxis für Pathologie Dr. Dykgers, Dr. Langwieder, Dr. Rees
Dortmund, , Germany
Städtisches Klinikum Dresden; Institut für Pathologie "Georg Schmorl" (Friedrichstadt)
Dresden, , Germany
Evangelisches Krankenhaus BETHESDA zu Duisburg GmbH; Institut für Pathologie
Duisburg, , Germany
Krankenhaus Düren gem. GmbH; Institut und Praxisgemeinschaft für Pathologie
Düren, , Germany
Universitätsklinikum Erlangen; Pathologisches Institut
Erlangen, , Germany
OptiPath Gemeinschaftspraxis für Pathologie
Frankfurt, , Germany
Universitätsklinikum Freiburg Institut f.Pathologie
Freiburg im Breisgau, , Germany
Pathologische Institut Friedrichshafen/Bodensee (Gemeinschaftspraxis für Pathologie und Zytologie)
Friedrichshafen, , Germany
Klinik am Eichert; Institut für Pathologie
Göppingen, , Germany
Universitätsklinikum Göttingen, Institut für Pathologie
Göttingen, , Germany
Institut für Pathologie, MVZ am Lukaskrankenhaus
Grevenbroich, , Germany
Klinikum Oberberg; Pathologisches Institut Kreiskrankenhaus Gummersbach
Gummersbach, , Germany
Pathologisches Institut am Allg. KH Stadt Hagen; Stambolis, Wolf von Rhüden, Ruwe
Hagen, , Germany
Universitätsklinikum Halle (Saale), Institut für Pathologie
Halle, , Germany
Kath. Marienkrankenhaus gGmbH
Hamburg, , Germany
Fachärzte Dres Tiemann & Schulte Partnerschaft; Institut für Hämatopathologie Hamburg
Hamburg, , Germany
Gemeinschaftspraxis für Pathologie Hamm, Dres. Diebold/Niemann
Hamm, , Germany
Gemeinschaftspraxis Dr. Hartmut Fitz, Dr. Sebastian Blasius und PD Dr. Christian August
Hanau, , Germany
Dres. Wolfgang Beschow Eckehardt Kupsch Herbert Radner u.w.
Hanover, , Germany
Medizinische Hochschule Hannover, Klinik für Frauenheilkunde und Geburtshilfe
Hanover, , Germany
Pathologisches Institut
Heidelberg, , Germany
Institut für Pathologie Hildesheim
Hildesheim, , Germany
Gemeinschaftspraxis für Pathologie Ingolstadt Dr. König, Dr. Popp, Prof. Dr. Adam
Ingolstadt, , Germany
Universitätsklinikum Jena; Institut für Pathologie
Jena, , Germany
Städtisches Klinikum Karlsruhe gGmbH; Pathologisches Institut
Karlsruhe, , Germany
Institut Für Pathologie Nordhessen
Kassel, , Germany
Institut für Pathologie Kassel
Kassel, , Germany
Institut für Pathologie, Universitäsklinikum Schleswig-Holstein
Kiel, , Germany
Klinikum Konstanz gGmbH, Institut und Praxis für Pathologie
Konstanz, , Germany
Gemeinschaftspraxis für Pathologie Lübeck; Turzynski, Lebeau, Gocht, Leuenroth
Lübeck, , Germany
Universitätsklinikum Magdeburg; Institut für Pathologie und Neuropathologie
Magdeburg, , Germany
Klinikum Magdeburg GmbH
Magdeburg, , Germany
Klinikum Mannheim; Pathologisches Institut
Mannheim, , Germany
Institut für Pathologie
Mühlhausen, , Germany
Pathologie München-Nord
München, , Germany
Institut für Pathologie der Universität Münster, Albert Schweitzer Campus, Gebäude D17
Münster, , Germany
Institut für Pathologie am Clemenshospital Münster
Münster, , Germany
Dietrich Bonhoeffer Kliniken Neubrandenburg, Institut für Pathologie
Neubrandenburg, , Germany
Zentrum für Pathologie, Zytologie und Molekularpathologie Neuss
Neuss, , Germany
Evangelisches Krankenhaus Oberhausen GmbH, Institut f.Pathologie
Oberhausen, , Germany
Pathocom - Gemeinschaftspraxis Bischofsstraße Osnabrück
Osnabrück, , Germany
Pathologisches Institut Recklinghausen
Recklinghausen, , Germany
Klinikum am Steinenberg / Ermstalklinik
Reutlingen, , Germany
Diakoniekrankenhaus Institut f.Pathologie
Rotenburg (Wümme), , Germany
Leopoldina Krankenhaus der Stadt Schweinfurt GmbH; Pathologie
Schweinfurt, , Germany
HELIOS Klinikum Schwerin; Frauenklinik
Schwerin, , Germany
Gemeinschaftspraxis PD Dr.med. Meinald Schultz und Dr.med. Petra Lüders
Stendal, , Germany
Robert-Bosch-Krankenhaus; Pathologisches Institut
Stuttgart, , Germany
Gemeinschaftspraxis für Pathologie Weiden; am Klinikum Weiden; Giedl, Stelter und Meier
Weiden, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML29763
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.